Publication | Closed Access

Cerebral muscarinic acetylcholinergic receptor measurement in Alzheimer’s disease patients on11C-N-methyl-4-piperidyl benzilate — Comparison with cerebral blood flow and cerebral glucose metabolism—

Neurodegenerative DiseasesAlzheimer's DiseaseMedicineCerebral Glucose Metabolism—NeuropharmacologyNeurochemical BiomarkersNeuroscienceNeurologyNeurodegenerationCerebral Blood FlowPharmacologyNeurochemistryGeriatric Neurology